Testing a seizure risk prediction app for focal epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a mobile app called EPIDAY that gives you a daily forecast of your seizure risk. It is designed for people with focal epilepsy who have seizures at least two days a month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have focal epilepsy (seizures starting in one part of the brain), and it has been diagnosed for at least 18 months.
- You have at least 2 days per month with seizures, but no more than 15 seizure days per month.
- You have a personal smartphone and can use a mobile app.
- You do not have other conditions that cause seizure-like symptoms (like non-epileptic attacks or fainting).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a wearable device that records brain activity to predict seizures. It might help you manage your epilepsy if you have seizures at least once a day but no more than two in the last three months.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study checks whether a new computer tool can help doctors interpret EEG results from adults who had a routine outpatient EEG after a possible seizure. It looks back at past records to see if the tool correctly spots seizure risk.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
This study tests a new ear-worn sensor to monitor brain activity. It will see if the device is safe and easy to use for recording seizures. Healthy volunteers and people with suspected seizures are both needed.
This study tests a new medication called RAP-219 to see if it can reduce seizure frequency in adults with focal epilepsy (seizures starting in one area of the brain). You'll take the medication alongside your current seizure drugs and track your seizures daily using an app.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.